Abstract
Background
The treatment for thyroid cancer is surgical. However, some patients do not undergo operations because of comorbidities or other reasons. There is little information about the prognosis of these patients. The aim of the present study was to describe patients with well differentiated thyroid carcinoma who did not undergo surgical treatment and to identify differences in prognostic variables and survival compared with patients treated surgically.
Methods
We conducted a retrospective review of a prospective cohort collected by the National Cancer Institute obtained from the Surveillance, Epidemiology and End Results (SEER) Program. All patient fi les with a diagnosis of thyroid cancer were selected (38,493 cases). Finally, 12,416 cases were used for the analysis. Treatment was divided into surgical or nonsurgical groups. Five-year survival rates were estimated and classifi ed by the SEER stage.
Results
Eighty-six patients did not receive surgical treatment. These patients were older, had more advanced tumours and their treatment was less associated with complementary radiotherapy. Five-year overall survival rates were 96.7% for surgical patients vs. 56.8% for nonsurgical patients (p<0.001). The overall survival in the nonsurgery group for localised tumours decreased 14.9%, for regional tumours decreased 49.9% and for distant tumours decreased 61.8%.
Discussion
The patients who did not undergo surgical treatment showed less than 5-year overall survival. The SEER database does not offer information about comorbidities that could explain these differences.
Similar content being viewed by others
References
Bondeson L, Ljungberg O (1981) Occult thyroid carcinoma at autopsy in Malmo, Sweden. Cancer 47:319–323
Ito Y, Miyauchi A, Inoue H et al (2010) An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg 34:28–35
Hay ID, Thompson GB, Grant CS et al (2002) Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 26:879–885
Margolis ML, Christie JD, Silvestri GA et al (2003) Racial differences pertaining to a belief about lung cancer surgery: results of a multicenter survey. Ann Intern Med 139:558–563
Sethi VK (1981) Non-surgical treatment of thyroid carcinoma. Ann Acad Med Singapore 10:372–375
Klepp O (1975) [Non-surgical treatment of thyroid neoplasms]. Tidsskr Nor Laegeforen 95:1287–1290
Halnan KE (1975) The non-surgical treatment of thyroid cancer. Br J Surg 62:769–771
Scott JS (1974) Nonsurgical treatment of thyroid tumours and its results. Proc R Soc Med 67:1106–1107
Halnan KE (1965) The place of non-surgical methods in diagnosis and management, and the long-term value of treatment of thyroid cancer. Br J Surg 52:736–739
Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295:2164–2167
Jefford M, Moore R (2008) Improvement of informed consent and the quality of consent documents. Lancet Oncol 9:485–493
Cady B, Sedgwick CE, Meissner WA et al (1979) Risk factor analysis in differentiated thyroid cancer. Cancer 43:810–820
Haigh PI, Urbach DR, Rotstein LE (2004) AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States. Surgery 136:609–616
Humphris GM, Ozakinci G (2006) Psychological responses and support needs of patients following head and neck cancer. Int J Surg 4:37–44
Kuijpens JL, Janssen-Heijnen ML, Lemmens VE et al (2006) Comorbidity in newly diagnosed thyroid cancer patients: a populationbased study on prevalence and the impact on treatment and survival. Clin Endocrinol (Oxf) 64:450–455
Shaha A (2008) Selective surgical management of well-differentiated thyroid cancer. Ann N Y Acad Sci 1138:58–64
Freeman HP, Chu KC (2005) Determinants of cancer disparities: barriers to cancer screening, diagnosis, and treatment. Surg Oncol Clin N Am 14:655–669, v
Sanabria A, Carvalho AL, Vartanian JG et al (2007) Factors that infl uence treatment decision in older patients with resectable head and neck cancer. Laryngoscope 117:835–840
Sanabria A, Carvalho AL, Vartanian JG et al (2007) Comorbidity is a prognostic factor in elderly patients with head and neck cancer. Ann Surg Oncol 14:1449–1457
Lee KY, Lore JM Jr (1990) The treatment of metastatic thyroid disease. Otolaryngol Clin North Am 23:475–493
Piccirillo JF (2000) Importance of comorbidity in head and neck cancer. Laryngoscope 110:593–602
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sanabria, Á., Domínguez, L.C., Vega, V. et al. Prognosis of patients with thyroid cancer who do not undergo surgical treatment: a SEER database analysis. Clin Transl Oncol 13, 692–696 (2011). https://doi.org/10.1007/s12094-011-0716-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-011-0716-8